2026-01-24 c.14F 1402會議廳
時間主題
11:00 ~ 11:25
Which regimen delivers the strongest start in first-line mRCC treatment?
講者: 蕭博任 座長: 李建儀
11:25 ~ 11:50
What Is the impact of deeper testosterone suppression on extending time to CRPC and improving survival?
講者: 蔡禮賢 座長: 李建儀
11:50 ~ 12:00
Panel discussion
講者: All 座長: 李建儀